Australian shares are trading lower on Wednesday, as investors await crucial inflation data out of the US. Data out of China has already showed that price ...
The results also showed margins were coming down, especially with rate hikes hitting home-loan margins. Meanwhile, the ANZ said in a statement that the Australian dollar was a touch lower after the US dollar "recovered some strength amid higher US bond yields". It said it was benefiting off strong crops yields, which were fetching high global prices as a crunch on supply continues due to the war in Ukraine. That was after it told the market that it had been knocked back by regulators in the United States to sell its baby formula there. Commonwealth Bank was 0.4 per cent lower, despite it putting out results that showed it was increasing its profit on the back of the impacts of the home-loan boom. Australian shares are trading lower on Wednesday, as investors await crucial inflation data out of the US and grapple with price hikes in China.
Commonwealth Bank of Australia (ASX:CBA) and Computershare Limited (ASX:CPU) shares will be on watch on the ASX 200 on Wednesday.
According to CNBC, the spot gold price is up 0.3% to US$1,810.90 an ounce. Looking ahead, the company is guiding to massive management EPS growth of 55% in FY 2023. The broker expects this to underpin a full year fully franked dividend of 380 cents per share. Energy producers such as Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) could have a poor day after oil prices softened overnight. According to a note out of Goldman Sachs, following the bank’s update on one-offs earlier this week, its analysts are now forecasting cash earnings of $9,509 million for FY 2022. The benchmark index rose 0.1% to 7,029.8 points.
The ASX weakened today ahead of the all-important inflation print in the US tonight with consensus tipping a result of +8.7% YoY. Tech fell on concerns bond ...
Relative to last year, gold production is expected to be flat to 12% high, while costs are expected up 13% at the midpoint. Follow my profile to be notified when the latest report is live. He is also Senior Portfolio Manager within Shaw and Partners heading up a team that manages... The move has the potential to add over $200m in annualised revenues, a significant asset base and deliver material synergies (if successfully delivered and ACCC approved). This event has been a long time coming as OVT has had material difficulties, of which COVID has exacerbated. A final distribution of 5.5c was as we expected while Assets under management was up 18% YoY to $20.6bn. There is a net loss of $37.9m that will gain the headlines, however that is a result of property revaluations. IGL +4.13%: Today announced they are the preferred party to negotiate and acquire their major competitor (Ovato) that recently went into administration. They guided gold production to 280-315koz, and all-in costs to $2050-2150/oz in the year ahead. CBA -0.28%: Released FY22 results this morning that were a touch stronger than expected. This week James & Harry cover portfolio performance for July across the suit of Market Matters Portfolios. Transparency is core to our approach and covering portfolio performance on the website, and via a video each and every month keeps our subscribers fully abreast of the outcomes we’re achieving. Inflation has caused costs to climb across the sector, particularly labour and energy costs, however, St Barbara also expects lower grade ore to be produced out of Gwalia putting further pressure on margins. CNI +2.96%: A solid update from Centuria this morning with few surprises for the property company that has fallen 45% over the past year – suffice to say, there was not a lot of upside built in! - Commonwealth Bank (ASX: CBA) -0.28% delivered a solid FY22 result today, a small beat on our numbers however it’s trading at such a premium to the others that we saw some rotation from CBA (trading 2.3x book) to ANZ (trading 1x book).
12:24 pm, 10 August 22 7 hours ago. Green energy stocks get a boost. All in all, 2022 is turning out to be a record year for global renewable energy ...
If the difference is negative—that is, if the real yield curve inverts—then growth is expected to decelerate. They see it going from 5.9% to 6.2% in the report to be released and maybe even 7% by year end. If the difference between the 10-year yield and 2-year yield is positive, then growth is expected to accelerate. This positive outlook is driving an increase in fourth quarter activity and supporting export volumes, forward contracted grain sales and supply chain margins. We are pleased to upgrade our FY22 earnings guidance, with both our Agribusiness and Processing businesses on track to deliver record financial results. After basically front-running the Fed’s pivot to jumbo rate hikes, the market is now fighting the Fed every step of the way as the central bank maintains an aggressive anti-inflation posture. As we mentioned last week, this landmark deal will bring in one of the most significant investments in clean energy until now. Fed Governor Michelle Bowman recently argued for continuing with the three-quarters percentage point hikes. And when they do, inflation won’t be a problem. Their role right now is to slow inflation by raising interest rates in order to tighten financial conditions. As CEO, Tennealle has done an excellent job delivering Adore Beauty’s financial and operational successes, including exceeding prospectus forecasts, and leaves the business well-positioned for future growth. O’Shannessy’s fixed annual remuneration will be set at $1.1 million, inclusive of benefits and allowances.
A sharp retreat in tech stocks and more modest falls in defensive assets were cushioned by gains in most of the major miners and banks. Commonwealth Bank ...
Management earnings per share increased by 10.6 per cent, allowing the board to increase the final dividend by 30 per cent. A2 Milk slumped 8.41 per cent after a setback in its bid to crack the US market. Computershare retreated 5.15 per cent as shareholders focussed on the negatives from a mixed full-year report. Full-year net profit climbed 9 per cent to $9.673 billion as core business volumes expanded and the bank reduced provisions made during the pandemic for bad loans. Operating expenses declined 1.5 per cent. Westpac rose 1.12 per cent. NAB gained 1.33 per cent. ANZ bounced 2.8 per cent. A progress update from a clinical trial helped raise Imugene 11.11 per cent. Mayne Pharma jumped 5.88 per cent after securing $679 million for its Metrics Contract Services business. A rare burst of independence has seen the domestic market largely ignore four straight losing nights on Wall Street. The S&P 500 shed 0.42 per cent overnight as traders reduced their exposure ahead of tonight’s nervously-anticipated July inflation report. The ASX 200 dropped as low as 6986 this morning before buyers pounced, raising the benchmark to 7021 by mid-session.